































targeted	as	potentially	preventable	 through	maternal	vaccination.	Other	existing	vaccines,	 like	hepatitis	E	or	pneumococcal	vaccines	 that	could	offer	additional	benefits	 in	 those	 first	weeks	of	 life	are	also	being
explored.
Bodies	like	the	Strategic	Advisory	Group	of	Experts	(SAGE)	on	Immunization	established	by	the	World	Health	Organization	(WHO),	the	Global	Vaccine	Action	Plan	(GVAP)	and	Gavi,	The	Vaccine	Alliance,	have


















The	 field	 is	 definitely	 in	 motion,	 but	 strong	 advocacy	 and	 good	 programmatic	 coordination	 are	 needed	 for	 accelerating	 results	 and	 outcome	 benefits.	 The	 over-arching	 goal	 of	 the	 WHO	 13th	 General
Programme	of	Work	(GPW	13)	translates	into	priorities	like	Universal	Health	Coverage	and	Healthier	Populations,	for	which	maternal	immunization	can	be	a	major	contributor	[10].	Major	initiatives	and	programs
should	consider	spelling	out	more	clearly	the	role	and	benefits	of	this	intervention	and	calling	for	specific	actions,	including	future	strategic	approaches	for	the	post	2020	immunization	strategy,	following	the	GVAP,	to
single	out	the	area	as	one	of	its	priorities	as	a	key	component	of	immunization	across	the	life	course.
Maternal	immunization	programs	also	offer	the	unique	opportunity	to	address	more	than	one	gap;	benefit	for	the	mother	and	for	the	infant.	Administration	through	the	antenatal	care	platform	may	be	the
preferred	way	and	at	the	same	time,	it	may	also	support	improved	attendance	at	prenatal	clinics	especially	in	middle	and	low-income	countries.	It	can	also	be	used	to	start	a	dialogue	on	prevention,	emphasizing	the
importance	of	timely	and	complete	vaccination	for	their	children.	Maternal	immunization	is	well	aligned	with	SDG3	and	a	core	pillar	of	Universal	Health	Care,	helping	to	ensure	the	health	of	mother	and	child	as	a
continuum	of	care.	Because	healthy	life	expectancy	has	not	increased	at	the	same	pace	as	life	expectancy,	approaches	that	can	significantly	contribute	to	healthier	outcomes	are	encouraged	by	GPW	13	to	be	adopted
by	all	countries	[10].
This	is	an	exciting	time	for	maternal	immunization	with	increasing	recognition	of	the	need	and	broader	public	health,	health	care	provider	and	public	engagement.	While	waiting	for	the	new	vaccines	like	RSV
and	GBS	and	optimizing	the	use	of	influenza	and	pertussis	there	is	momentum	now	to	coordinate	efforts,	address	the	missing	information	and	action	gaps,	and	call	to	accelerate	progress.
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